Inventor profile of:

Alexander Oksche

City:

Limburg

Country:

Germany

Published Applications:

18

Last publication date:

2026-04-23

Top Assignees for applications by Alexander Oksche

The entities that hold a legal rights for patent applications filed by inventor Oksche Alexander:

Recent patent applications by Oksche Alexander

Alexander Oksche from Limburg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23
US20260108456A1
Human necessities

INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE

#2 | 2024-03-14
US20240082149A1
Human necessities

INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE

#3 | 2021-11-04
US20210338574A1
Human necessities

Intranasal pharmaceutical dosage forms comprising naloxone

#4 | 2019-12-12
US20190374464A1
Human necessities

Intranasal pharmaceutical dosage forms comprising naloxone

#5 | 2019-07-18
US20190216797A1
Human necessities

Buprenorphine-wafer for drug substitution therapy

#6 | 2018-01-11
US20180008595A1
Human necessities

BUPRENORPHINE WAFER FOR DRUG SUBSTITUTION THERAPY

#7 | 2017-10-26
US20170304192A1
Human necessities

INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE

#8 | 2017-08-17
US20170231904A1
Human necessities

Intranasal Pharmaceutical Dosage Forms Comprising Naloxone

#9 | 2017-06-08
US20170157062A1
Human necessities

Buprenorphine-Wafer for Drug Substitution Therapy

#10 | 2016-08-18
US20160235739A1
Human necessities

Buprenorphine-wafer for drug substitution therapy

#11 | 2016-08-18
US20160235738A1
Human necessities

Buprenorphine-wafer for drug substitution therapy

#12 | 2016-06-30
US20160184293A1
Human necessities

Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

#13 | 2015-11-19
US20150328143A1
Human necessities

Buprenorphine-wafer for drug substitution therapy

#14 | 2015-05-07
US20150126540A1
Human necessities

Intranasal Pharmaceutical Dosage Forms Comprising Naloxone

#15 | 2015-01-22
US20150025102A1
Human necessities

Buprenorphine-Wafer for Drug Substitution Therapy

#16 | 2015-01-15
US20150018379A1
Human necessities

Intranasal Pharmaceutical Dosage Forms Comprising Naloxone

#17 | 2012-04-19
US20120093929A1
Human necessities

Opioid composition for treating skin lesions

#18 | 2010-04-08
US20100087470A1
Human necessities

Buprenorphine-wafer for drug substitution therapy

InventorID:

1037541 ⎘